Search research articles
Contact Us
Filters
Showing results (201-210 of 277) with videos related to
Page
of 28
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
March 18, 2019
Immune Signatures Associated With Clonal Isotype Switch After Autologous Stem Cell Transplantation for Multiple Myeloma
Rebecca Ye, Sirisha Kundrapu, Stanton L Gerson, et al.
The Journal of Pediatrics
|
February 15, 2026
Preventing Post-Vaccination Presyncope and Syncope in Adolescents: A Randomized Controlled Trial of a Clinic-Based Intervention
Michael J Smith, Theresa A Harrington, Richard J Chung, et al.
Cells
|
May 21, 2020
Liver Sinusoidal Endothelial Cells Contribute to Hepatic Antigen-Presenting Cell Function and Th17 Expansion in Cirrhosis
Esther Caparrós, Oriol Juanola, Isabel Gómez-Hurtado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts
G L DeNardo, L A Kroger, C F Meares, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 20, 1998
Yttrium-90-DOTA-peptide-chimeric L6 radioimmunoconjugate: efficacy and toxicity in mice bearing p53 mutant human breast cancer xenografts
S J DeNardo, D L Kukis, L A Miers, et al.
Leukemia
|
March 4, 2005
AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells: interference with the Akt/NF-kappaB survival pathway
E Escobar-Díaz, E M López-Martín, M Hernández del Cerro, et al.
American Heart Journal
|
November 5, 2021
Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorb™-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose
C Michael Gibson, Michael J Mack, Victoria T Lee, et al.
Cancers
|
December 9, 2020
Mapping the Relative Biological Effectiveness of Proton, Helium and Carbon Ions with High-Throughput Techniques
Lawrence Bronk, Fada Guan, Darshana Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 1999
Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A
C M Richman, S J DeNardo, R T O'Donnell, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 31, 2000
Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy
S J DeNardo, P A Burke, B R Leigh, et al.
Page
of 28
Search research articles
Search
Showing results (201-210 of 277) with videos related to
Sort By:
Page
of 28
Clinical Lymphoma, Myeloma & Leukemia
|
March 18, 2019
Immune Signatures Associated With Clonal Isotype Switch After Autologous Stem Cell Transplantation for Multiple Myeloma
Rebecca Ye, Sirisha Kundrapu, Stanton L Gerson, et al.
The Journal of Pediatrics
|
February 15, 2026
Preventing Post-Vaccination Presyncope and Syncope in Adolescents: A Randomized Controlled Trial of a Clinic-Based Intervention
Michael J Smith, Theresa A Harrington, Richard J Chung, et al.
Cells
|
May 21, 2020
Liver Sinusoidal Endothelial Cells Contribute to Hepatic Antigen-Presenting Cell Function and Th17 Expansion in Cirrhosis
Esther Caparrós, Oriol Juanola, Isabel Gómez-Hurtado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts
G L DeNardo, L A Kroger, C F Meares, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 20, 1998
Yttrium-90-DOTA-peptide-chimeric L6 radioimmunoconjugate: efficacy and toxicity in mice bearing p53 mutant human breast cancer xenografts
S J DeNardo, D L Kukis, L A Miers, et al.
Leukemia
|
March 4, 2005
AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells: interference with the Akt/NF-kappaB survival pathway
E Escobar-Díaz, E M López-Martín, M Hernández del Cerro, et al.
American Heart Journal
|
November 5, 2021
Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorb™-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose
C Michael Gibson, Michael J Mack, Victoria T Lee, et al.
Cancers
|
December 9, 2020
Mapping the Relative Biological Effectiveness of Proton, Helium and Carbon Ions with High-Throughput Techniques
Lawrence Bronk, Fada Guan, Darshana Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 1999
Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A
C M Richman, S J DeNardo, R T O'Donnell, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 31, 2000
Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy
S J DeNardo, P A Burke, B R Leigh, et al.
Page
of 28